Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Davecia Ragoonath Cameron"'
Autor:
Kinjal Parikh, Shanu Modi, Richard Caraico, Nabil Dorkhom, Pan Chen, Kelly Hanley, Davecia Ragoonath Cameron
Publikováno v:
Cancer Research. 81:PS9-64
Background:The treatment armamentarium for patients with refractory metastatic HER2+ breast cancer was limited due to a lack of effective agents after the use of ado-trastuzumab emtansine, trastuzumab, and pertuzumab. Novel therapies such as trastuzu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00660e98c49d09b7a2c7be5af190d4a5
https://doi.org/10.1158/1538-7445.sabcs20-ps9-64
https://doi.org/10.1158/1538-7445.sabcs20-ps9-64
Autor:
Pan Chen, Sara M. Tolaney, Mindy Tanzola, Kinjal Parikh, Pamela Peters, Davecia Ragoonath Cameron, Nabil Dorkhom
Publikováno v:
Cancer Research. 81:PS9-40
Background:Recently, CDK4/6 inhibitors have revolutionized the care of patients with hormone receptor (HR)-positive, HER2-negative breast cancer, improving survival outcomes. Already, there are multiple CDK4/6 inhibitors available that differ in thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45535cf0569d916f858dc6e6ed7c054e
https://doi.org/10.1158/1538-7445.sabcs20-ps9-40
https://doi.org/10.1158/1538-7445.sabcs20-ps9-40
Publikováno v:
Journal of Clinical Oncology. 40:e12509-e12509
e12509 Background: Hormone receptor positive breast cancer (HR+ BC) is often diagnosed in the early, curable, stage. Emerging treatment options make it important to educate clinicians on how to identify patients eligible for these options and increas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc18334fac8d4cd06f136787355f0271
https://doi.org/10.1200/jco.2022.40.16_suppl.e12509
https://doi.org/10.1200/jco.2022.40.16_suppl.e12509
Publikováno v:
Blood. 136:28-29
Background: Myeloproliferative neoplasms (MPNs) are rare malignancies that include myelofibrosis (MF), polycythemia vera (PV), and essential thrombocythemia. The objective of this study is to assess current clinical practices of hematologist/oncologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfb30e5b62b382bf64f2c65a924a8c2d
https://doi.org/10.1182/blood-2020-136179
https://doi.org/10.1182/blood-2020-136179
Publikováno v:
Journal of Clinical Oncology. 39:347-347
347 Background: Chemotherapy is a mainstay treatment modality for patients with advanced cholangiocarcinoma (CCA). Recent developments and new approvals have led to changing paradigms, incorporating the use of targeted therapies for patients with pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1943b2a2d34ade1b75e8f2406215ea1
https://doi.org/10.1200/jco.2021.39.3_suppl.347
https://doi.org/10.1200/jco.2021.39.3_suppl.347
Publikováno v:
Journal of Clinical Oncology. 39:137-137
137 Background: The treatment armamentarium for patients with metastatic colorectal cancer (mCRC) has expanded significantly and treatment options for progressive disease remain limited. As data from clinical trials or subgroup analyses become availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff9fedfb0014cbbf693873dd65b9f1f5
https://doi.org/10.1200/jco.2021.39.3_suppl.137
https://doi.org/10.1200/jco.2021.39.3_suppl.137
Publikováno v:
Journal of Clinical Oncology. 39:248-248
248 Background: Care of patients with gastric/GEJ cancer involves multimodality treatment including various systemic and supportive approaches and collaboration of interdisciplinary team members. Optimizing care requires not only adherence to the lat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48c8b0d6cc443388f0d224c0a9a69725
https://doi.org/10.1200/jco.2021.39.3_suppl.248
https://doi.org/10.1200/jco.2021.39.3_suppl.248
Publikováno v:
Annals of Oncology. 31:S163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7772a95d882c357e296c3b20dc5163b
https://doi.org/10.1016/j.annonc.2020.04.306
https://doi.org/10.1016/j.annonc.2020.04.306
Autor:
Kenneth C. Anderson, Davecia Ragoonath Cameron, Andrew D. Bowser, Jim Mortimer, Sagar Lonial, Amitabha Mazumder, Kevin L Obholz
Publikováno v:
Blood. 124:1298-1298
Clinical practice guidelines in MM list many therapeutic choices, with similar levels of evidence, but frequently lack specific recommendations for individual patient cases. We sought to determine whether expert recommendations on MM treatment, based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a3c8af16cea61c0625d3126140ccafa
https://doi.org/10.1182/blood.v124.21.1298.1298
https://doi.org/10.1182/blood.v124.21.1298.1298